From the category archives:

MedWatch

Infinity: Public Notification – Undeclared Drug Ingredient

April 11, 2014

Use may increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. This is a summary of an alert issued by MedWatch: The FDA Safety Information and Adverse Event Reporting Program. The link below will [...]

Read More Details →

Lite Fit USA: Public Notification – Undeclared Drug Ingredient

April 11, 2014

Use may increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. This is a summary of an alert issued by MedWatch: The FDA Safety Information and Adverse Event Reporting Program. The link below will [...]

Read More Details →

March 2014

April 11, 2014

Safety Labeling Changes includes 30 products with revisions to Prescribing Information. Posted 04/11/2014. This is a summary of an alert issued by MedWatch: The FDA Safety Information and Adverse Event Reporting Program. The link below will take you to the original notice. View Full Details Of The Original MedWatch Notice Here.

Read More Details →

Zi Xiu Tang Bee Pollen Capsules by Guangzhou Zi Xiu Tang Biotechnology Co., Ltd: Warning – Undeclared Drug Ingredients

April 8, 2014

Risk of increased blood pressure and/or pulse rate. This is a summary of an alert issued by MedWatch: The FDA Safety Information and Adverse Event Reporting Program. The link below will take you to the original notice. View Full Details Of The Original MedWatch Notice Here.

Read More Details →

PS500 Power Supply Unit by Dräger: Recall – Early Depletion of Battery Charge

April 2, 2014

Battery depletion will require manual ventilation until the device is connected to main power. This is a summary of an alert issued by MedWatch: The FDA Safety Information and Adverse Event Reporting Program. The link below will take you to the original notice. View Full Details Of The Original MedWatch Notice Here.

Read More Details →

Revatio (sildenafil): Drug Safety Communication – FDA Clarifies Warning About Pediatric Use for Pulmonary Arterial Hypertension

March 31, 2014

Health care professionals must consider whether the benefits of treatment with the drug are likely to outweigh its potential risks for each patient. This is a summary of an alert issued by MedWatch: The FDA Safety Information and Adverse Event Reporting Program. The link below will take you to the original notice. View Full Details [...]

Read More Details →

Revatio (sildenafil): Drug Safety Communication – FDA clarifies Warning About Pediatric Use for Pulmonary Arterial Hypertension

March 31, 2014

Health care professionals must consider whether the benefits of treatment with the drug are likely to outweigh its potential risks for each patient. This is a summary of an alert issued by MedWatch: The FDA Safety Information and Adverse Event Reporting Program. The link below will take you to the original notice. View Full Details [...]

Read More Details →

Nova Products, Inc. Dietary Supplements: Recall – Undeclared Drug Ingredients

March 31, 2014

Sildenafil and tadalafil can interact with nitrates found in some prescription drugs (such as nitroglycerin), resulting in decreased blood pressure. This is a summary of an alert issued by MedWatch: The FDA Safety Information and Adverse Event Reporting Program. The link below will take you to the original notice. View Full Details Of The Original [...]

Read More Details →

Alli (60 mg orlistat capsules) by GlaxoSmithKline: Recall – Product Tampering

March 28, 2014

Some packages of the product were tampered with and may contain product that is not authentic. This is a summary of an alert issued by MedWatch: The FDA Safety Information and Adverse Event Reporting Program. The link below will take you to the original notice. View Full Details Of The Original MedWatch Notice Here.

Read More Details →

Bella Vi Brand Products by Pure Edge Nutrition: Recall – Undeclared Drug Ingredients

March 26, 2014

Sibutramine can increase blood pressure and/or pulse rate in some patients and may present a risk for those with a history of coronary artery disease, congestive heart failure, arrhymias or stroke. This is a summary of an alert issued by MedWatch: The FDA Safety Information and Adverse Event Reporting Program. The link below will take [...]

Read More Details →